Paper Details 
Original Abstract of the Article :
This study evaluated efficacy and safety of growth hormone treatment in Duchenne muscular dystrophy boys with glucocorticoid-induced growth failure. We reviewed 39 consecutive boys (average age 11.5 years; 32 ambulatory) treated with growth hormone for 1 year during a four-year period. Boys were on ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.nmd.2012.07.009

データ提供:米国国立医学図書館(NLM)

Growth Hormone Treatment for Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD) is a severe genetic disorder that causes progressive muscle weakness and degeneration. This research examines the effectiveness of growth hormone treatment for boys with DMD who have experienced growth failure due to glucocorticoid therapy. The study delves into the impact of growth hormone on growth velocity, height-for-age z-scores, and other important clinical outcomes, while also assessing the safety of this treatment. The authors present a review of 39 consecutive boys with DMD who received growth hormone therapy, offering valuable insights into its potential benefits and risks.

Growth Hormone Improves Growth in Boys with DMD

The study reveals that growth hormone treatment significantly improved growth velocity and stabilized height-for-age z-scores in boys with DMD and glucocorticoid-induced growth failure. The authors report a substantial increase in growth velocity and a marked improvement in height, suggesting that growth hormone can effectively address the growth challenges associated with DMD and glucocorticoid therapy. These findings offer a glimmer of hope for improving the overall well-being of boys with DMD.

Managing DMD: Optimizing Treatment and Quality of Life

DMD is a complex and challenging condition that requires a comprehensive approach to management. This study highlights the importance of considering growth hormone therapy as a potential treatment option for boys with DMD who are experiencing growth failure. By addressing growth issues and improving overall well-being, healthcare providers can enhance the quality of life for boys with DMD and optimize their overall care.

Dr. Camel's Conclusion

The desert of DMD can be a difficult journey, with challenges related to muscle weakness and growth impairment. This study sheds light on the potential benefits of growth hormone therapy in improving growth and overall well-being for boys with DMD. By understanding the potential of this treatment and working closely with their healthcare team, patients can find their way toward a brighter future, navigating the desert of DMD with greater strength and resilience.

Date :
  1. Date Completed 2013-06-12
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

22967789

DOI: Digital Object Identifier

10.1016/j.nmd.2012.07.009

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.